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Abstract
Background: While almost all infants are infected with respiratory syncytial virus (RSV) before the age of 2 years, only a
small percentage develops severe disease. Previous studies suggest that the nasopharyngeal microbiome affects
disease development. We therefore studied the effect of the nasopharyngeal microbiome on viral load and mucosal
cytokine responses, two important factors influencing the pathophysiology of RSV disease. To determine the relation
between (i) the microbiome of the upper respiratory tract, (ii) viral load, and (iii) host mucosal inflammation during an
RSV infection, nasopharyngeal microbiota profiles of RSV infected infants (< 6 months) with different levels of disease
severity and age-matched healthy controls were determined by 16S rRNA marker gene sequencing. The viral load was
measured using qPCR. Nasopharyngeal CCL5, CXCL10, MMP9, IL6, and CXCL8 levels were determined with ELISA.
Results: Viral load in nasopharyngeal aspirates of patients associates significantly to total nasopharyngeal microbiota
composition. Healthy infants (n = 21) and RSV patients (n = 54) display very distinct microbial patterns, primarily
characterized by a loss in commensals like Veillonella and overrepresentation of opportunistic organisms like
Haemophilus and Achromobacter in RSV-infected individuals. Furthermore, nasopharyngeal microbiota profiles are
significantly different based on CXCL8 levels. CXCL8 is a chemokine that was previously found to be indicative for
disease severity and for which we find Haemophilus abundance as the strongest predictor for CXCL8 levels.
Conclusions: The nasopharyngeal microbiota in young infants with RSV infection is marked by an overrepresentation
of the genus Haemophilus. We present that this bacterium is associated with viral load and mucosal CXCL8 responses,
both which are involved in RSV disease pathogenesis.
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Background
Respiratory syncytial virus (RSV) is a major cause of re-
spiratory tract infections in young children that fre-
quently leads to hospitalization [1]. The clinical
symptoms vary from upper respiratory tract infection to
severe bronchiolitis with respiratory insufficiency for
which mechanical ventilation is needed. Despite the high
disease burden of RSV in young children, no antivirals,
vaccines, or other targeted treatments for bronchiolitis
have proven to be beneficial yet, and therefore, only sup-
portive care is currently recommended [1–3]. Prematur-
ity, young age (< 6 months), and the presence of siblings
or daycare attendance are important risk factors for se-
vere RSV disease requiring hospitalization and respira-
tory support, indicating that development of the
immune system as well as environmental factors plays a
role in the pathogenesis of RSV bronchiolitis [4–6].
To date, it is thought that the host response to the
virus contributes most prominently to the key features
of bronchiolitis, marked by swelling of the mucosa, se-
cretion of mucus, and eventually obstruction of the
smaller airways [6–9]. In addition, high viral load in the
lungs and nasopharynx have been found in children with
severe infection, suggesting that viral replication also
contributes to increased pathology [10–12]. During the
inflammatory response induced by the virus, cytokines
and chemokines are released and attract circulating leu-
kocytes to the site of infection. As recently reviewed by
Russel et al., CXCL-8 and CXL-10 have been associated
with immune pathology, whereas CCL-5 in general is as-
sociated with a more beneficial immune response [7]. It
seems that a balanced inflammatory response with influx
of immune cells is crucial, as indicated by near absence
of cytotoxic CD8 cells in fatal cases of RSV bronchiolitis
and the presence of massive influx of neutrophils in the
lumen of the airways of most severe infections [13, 14].
The importance of the inflammatory response in the de-
velopment of severe disease is further underlined by the
association of the level of circulating immune cells and
secreted cytokines with disease severity [15].
Respiratory mucosal surfaces are colonized directly
after birth with bacteria from the mother, and the com-
position changes dramatically during the first years of
life depending on genetics and environmental factors
[16–18]. These commensal bacteria release components
such as lipopolysaccharides and peptidoglycans that have
been shown to pass the epithelial barrier of the mucosal
lining under non-inflammatory conditions [19]. This
translocation of bacterial products increases during in-
flammation [20, 21]. Induction of the initial innate im-
mune response in epithelial cells and immune cells by
RSV and the secretion of cytokines and chemokines
should therefore be considered in the presence of these
bacterial products [22].
Findings from the MARC-35 bronchiolitis cohort by
Mansbach and coworkers, a prospective study of 1016
infants below 1 year of age hospitalized with bronchio-
litis, underpin the importance of bacterial colonization
of the respiratory tract during viral infection [23]. They
show that depending on infection with RSV and rhino-
virus, different compositions of nasopharyngeal micro-
biota are found, mainly higher levels of Streptococcus
and Haemophilus/Moraxella, respectively. Steenhuijsen
Piters and co-workers recently showed that clusters
characterized by the dominance of Haemophilus (influ-
enzae) and Streptococcus were positively associated with
RSV infection and RSV-related hospitalization, based on
nasopharyngeal microbiota clusters that were stratified
prior to analyses [24]. In addition, they reported en-
hanced expression of host genes linked to inflammation
and immune signaling in patients with the two micro-
biota clusters (Haemophilus and Streptococcus domi-
nated), suggesting that interactions between RSV and
specific components of the nasopharyngeal microbiota
modulate the host immune response, potentially driving
clinical disease severity. These findings are further sup-
ported by the association of specific metabolic profiles in
respiratory samples with severe bronchiolitis, which
could be linked to the composition of the microbiome
[25]. In this study, we investigate the association of the
nasopharyngeal microbiota, without prior stratification
on microbiota types, to RSV load, nasopharyngeal cyto-
kine responses, and the association with disease severity.
Results
RSV study cohort and baseline characteristics.
We retrospectively selected a cohort of 54 infant pa-
tients younger than 6 months of age, who were hospi-
talized with an RSV infection, and 21 age-matched
healthy infants (Fig. 1a, Table 1, and Additional file 1:
Table S1A). Patients were stratified based on severity of
RSV disease using clinically defined parameters as fol-
lows: mild disease included children without hypoxemia
(n = 9); moderate disease included children receiving
supplemental oxygen (n = 27); and severe disease in-
cluded children requiring mechanical ventilation (n =
18) (Fig. 1b). We collected nasopharyngeal aspirate
(NPA) samples from a subset of RSV patients (n = 25)
4–6 weeks after hospital discharge, enabling us to
evaluate mucosal immune responses and the micro-
biome after recovery of disease (n = 2, 16, and 7, for
mild, moderate, and severe, respectively). NPA samples
were collected in which bacterial composition, viral
load, and host immune responses were measured to
allow for integrated analysis (Fig. 1c).
To account for potential confounding variables, we
screened our cohort on various parameters such as gen-
der, age, (birth) weight, and RSV viral load (Table 1 and
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Fig. 1 Study design. Graphical summary of the study focus, design, and analysis, as adopted in this manuscript
Table 1 Descriptive characteristics of the study samples (n = 75)
No. of participants
(n = 75)
Control Mild Moderate Severe Recovery
n = 21 n = 9 n = 27 n = 18 n = 25
Age (days) 89 (37) 88 (29) 75 (50) 37 (21) 109 (48)
Hospital Stay (days) 0 (0) 3 (3) 8 (5) 14 (6) 0 (0)
RSV viral load (Ct) 50.0 (0) 22.4 (3.3) 27.0 (5.4) 23.6 (3.4) 50.0 (0)
Weight (gram) N/A N/A 14,674 (21111) 5516 (2002) 3874 (931) 5375 (2333)
Birth weight (gram) 2624 (768) 3323 (618) 3271 (656) 2867 (738) 3116 (677)
% antibiotics 0% 22% 7% 11% 8%
% breastfed 38% 67% 56% 72% 76%
% males 24% 56% 52% 44% 44%
Mean number of reads 27,449 (4464) 24,916 (4826) 21,787 (5776) 28,866 (32974) 22,658 (5208)
Total number of reads 5.76E+05 2.24E+05 5.88E+05 5.20E+05 5.66E+05
Assigned at family 99.72% (0.01%) 99.88% (0.01%) 99.90% (0.01%) 99.94% (0.01%) 99.91% (0.01%)
Assigned at genus 94.72% (0.07%) 97.91% (0.03%) 98.98% (0.02%) 98.15% (0.03%) 97.89% (0.04%)
Assigned at speciesa 21.22% (0.19%) 8.07% (0.06%) 10.25% (0.09%) 10.27% (0.09%) 8.43% (0.17%)
Mean number of OTUs 203 (56) 167 (44) 139 (38) 150 (38) 160 (50)
Total number of OTUs 4270 1499 3756 2705 3999
Mean Chao indexb 176.8 (54.4) 151.7 (42.6) 131.1 (39.4) 137.5 (17.8) 150.2 (53.5)
Mean Shannon indexb 3.1 (1.1) 2.8 (0.7) 2.4 (0.8) 2.7 (0.7) 2.4 (0.8)
Mean PDWT indexb 6.0 (1.7) 5.6 (1.1) 5.1 (1.6) 4.9 (0.9) 6.1 (2.0)
Data are presented as average + standard deviation (SD) for continuous variables and as percentages for categorical variables. Numbers listed in brackets: SD. The
antibiotic use was at the time of infection, and breastfeeding duration was not specified
aNote that due to technical limitations in the resolution of 16S marker gene sequencing, OTU (Operational Taxonomic Unit) calling on the level of species should
be interpreted with caution
bAlpha diversity metrics
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Additional file 2: Figure S1). Infant age (and gender to a
minor extent) was found to be unevenly distributed over
our cohort, which is likely a consequence of age being a
known risk factor for developing (severe) RSV infection
[26]. Birth weight, although not significantly different
between study groups, did show a trend towards being
increased in RSV patients in comparison to healthy in-
fants. Antibiotic use was evenly distributed over the RSV
patient severity stratifications (Table 1); none of the
healthy infants used antibiotics at time of enrollment.
Altogether, this prompted us to correct for age, gender,
and birth weight effects in multivariate analyses
throughout this study. We also assessed viral co-
infections, for which we found that only coronavirus
(11%) and rhinovirus (20%) had a high prevalence. How-
ever, patients with these co-infections appeared to be
randomly distributed in the disease severity stratifica-
tions (Additional file 1: Table S1B).
Nasopharyngeal microbiota composition
16S rRNA marker gene Illumina sequencing (16S) of the
V3-V4 region was used to study the consortia of bacteria
present in the NPA samples. By adopting a customized
QIIME-based workflow for analysis of sequencing reads,
we were able to classify 97.6% of sequencing reads with
confidence to the genus-level and study-wide identified a
total of 156 unique genera (Additional file 3: Table S2 and
Additional file 4: Table S3). Sufficient sequencing reads and
OTU (operational taxonomic unit) counts for each sample
were realized with an average of 25k ± 15k SD reads and
162 ± 51 SD OTUs, respectively (Table 1 and Add-
itional file 3: Table S2). We identified Haemophilus (30.5%
relative abundance on average; healthy and RSV-infected
individuals combined), Streptococcus (29.4%), Moraxella
(10.7%), Corynebacterium (6.89%), and Staphylococcus
(2.9%) as the main genera (and known to be typically
present) in the nasopharynx (Fig. 2) [24]. In addition, we
found minor levels of Prevotella (4.2%), Achromobacter
(3.6%), Neisseria (2.2%), and Veillonella (1.4%) representing
additional genera (Fig. 2).
RSV disease, viral load, and CXCL8 levels can be
explained by nasopharyngeal microbial make-up.
To examine the microbial involvement in RSV disease pro-
cesses, redundancy analysis (RDA) was performed and
showed a strong and significant separation of RSV patients
and healthy controls based on NPA microbial makeup
(Fig. 3a; p = 0.001). This difference in contrast is mainly
characterized by Haemophilus and Achromobacter, not by
Agrobacterium, as this bacterium is only represented by
three RSV samples with < 0.01% relative abundance each.
Both viral load and host immune responses are hypothe-
sized to play a major role in the disease processes, through
which microbiota could potentially (directly or indirectly)
assert their effect on the pathophysiology and the course of
disease. Therefore, we further focused on differences in
microbiota content between different viral loads and host
cytokines and chemokines that were previously described
to be relevant in RSV disease (CCL5, CXCL8/IL8, CXCL10,
IL6, and MMP9) [15, 27, 28].
We found that RSV viral load (as determined with
qPCR, Ct) in nasopharyngeal aspirates of patients was
associated significantly with total nasopharyngeal micro-
biota composition (Fig. 3b; RDA p = 0.036), although no
statistically different viral loads between the patient RSV
severity stratifications could be detected (Additional file 1:
Table S1A). However, because the response variables of
the data in the RDA are also strongly oriented in the
vertical direction, this indicates that separation based on
genus-level microbiota is not primarily driven by the
viral load contrast.
Furthermore, RDA of healthy and RSV-infected individ-
uals showed that nasopharyngeal genus-level microbiota
can significantly be separated based on levels of CXCL8
(Fig. 3c; RDA p = 0.036) but not for any of the other can-
didate markers (data not shown). Strikingly, in this RDA,
Haemophilus is among the most important genera con-
tributing to the observed separation, as its arrow points to
CXCL8 in a strong horizontal direction. Helcococcus, al-
though its arrow is also strongly horizontally oriented, has
a very low abundance (0.01% on average).
The above-described genus-level RDA analyses (Fig. 3)
were repeated with higher resolution OTU-level micro-
biota data (clustering on 97.0%), and on this level of taxo-
nomical detail, similar statistical significances and
microbial associations were observed (Additional file 2:
Figure S2). Mainly, OTUs classified to genus or species of
Haemophilus were found to be important in driving these
outcomes and Streptococcus to a lesser extent. However,
we did lose significance for the association of CXCL8 with
microbiota on the level of OTU in comparison to genus
(p = 0.036 to p = 0.089; Additional file 2: Figure S2C),
which might in part be governed by birth weight, as re-
moval of birth weight as confounding factor resulted in
restoring of statistical significance as observed at the level
of genus (p = 0.02; data not shown). Interestingly, OTU-
level analysis of microbiota associated with RSV viral load
provided increased insight with regard to Haemophilus-
classified OTUs, as these best explained association with
viral load but not other OTUs in the top 10 response vari-
ables (Additional file 2: Figure S2B). Furthermore, the
above-described association of Helcococcus with levels of
CXCL8 was not observed on the level of OTU (Add-
itional file 2: Figure S2C) and, instead, was likewise best
explained by OTUs classified as Haemophilus taxa. In
conclusion, Haemophilus seems to be a strong correlate to
the outcome for clinical manifestation of RSV disease,
viral load, and CXCL8 immune response.
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RSV disease is marked with increased populations of
Haemophilus and Achromobacter
Further evaluation of microbial nasopharyngeal (alpha) di-
versity between study groups suggested that RSV infection
is characterized by decreased species richness (p = 0.006;
MWU, corrected), which is more pronounced in moderate
and severe disease compared to controls (p = 0.016 and
p = 0.024) (Additional file 2: Figures S3A and S3C). Re-
garding species diversity, no significant differences associ-
ated with RSV-infected infants or severity of disease were
found (Additional file 2: Figures S3B and S3D). A trend in
reduction of species diversity in RSV patients was observed
here (p = 0.098), and this species diversity, interestingly, is
partly restored after disease recovery (p = 0.060, uncor-
rected; Additional file 2: Figure S3B). Furthermore, micro-
bial makeup of the nasopharynx of RSV-infected compared
to healthy individuals was characterized by a strong and
significant overrepresentation of Haemophilus (Fig. 4), in-
creasing from 11.8 to 37.8% relative abundance (p = 0.011;
MWU, corrected) and (with lower abundance) of Achro-
mobacter (Additional file 2: Figure S4A; increasing from
0.7 to 4.7%; p = 0.001). After recovery from RSV disease,
based on a paired sample analysis, the level of Haemophi-
lus was restored in these infants and was found to be
Fig. 2 Nasopharyngeal microbiota composition in healthy and RSV-infected infants. Each leaf of the tree represents a single sample. Samples were
clustered based on beta diversity (‘between-sample distance’), using weighted UniFrac as a distance measure and hierarchical UPGMA as a clustering
method. Vertical bars show the relative abundance microbiota composition on the genus level (reads that could not be classified up to this level are in
white). The 20 most dominant genera are shown in the legend. Colored sample labels represent sample classes: mild (orange), moderate (light red), or
severe (dark red) disease; healthy control (green); and recovery (blue) samples. The figure was generated with the interactive tree of life (iTOL) program
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similar to the level of healthy volunteers (Fig. 4b). In con-
trast, a significant underrepresentation of Veillonella and
Leptotrichia was observed during RSV infection (Add-
itional file 2: Figures S4B and S4C), which however might
be a consequence of the increase of the aforementioned
bacteria. On a side note, Moraxella appeared to be primar-
ily present in recovery samples from RSV-infected individ-
uals (Fig. 2 and Additional file 2: Figure S5). In conclusion,
RSV infection caused a strong microbial perturbation char-
acterized by presence of Haemophilus and Achromobacter.
Mucosal IL6 and CXCL8 responses correlate with clinical
RSV disease severity but not with a specific microbiota
profile
Local host response measurements in the NPA indicated
that cytokines and chemokines are either negatively
(CCL5, CXCL10, and MMP9; Fig. 5a) or positively (CXCL8
and IL6; Fig. 5b) correlating with RSV disease severity. This
was statistically confirmed for IL6 and CXCL8 by Spear-
man correlation (p = 0.0009/rho = 0.39 and p = 0.0001/rho
= 0.51, respectively; uncorrected), although between RSV
sample groups only, we did not find significant differences
with ANOVA. As severity measure based on oxygen and
mechanical ventilation requirement is a non-continuous
value, we validated the above numbers by correlating with
duration of hospital stay, which is an accepted measure of
RSV severity, and found similar correlations (p = 0.0005/
rho = 0.41 and p = 0.0003/rho = 0.46, for IL6 and CXCL8,
respectively; uncorrected). Furthermore, paired analysis
with recovery samples indicated that the IL6 and CXCL8
cytokine responses were restored to normal levels after re-
covery from RSV disease, as the responses after recovery
were significantly lower than for their corresponding
sample upon disease (IL6 p = 0.02; CXCL8 p = 0.005;
Additional file 2: Figure S6).
In line with our findings as described above, RDA indi-
cated that healthy infants and RSV-infected patients do in-
deed display very distinct microbial patterns (Fig. 6a; RDA
p = 0.007). However, this RDA separation seemed to be
primarily driven by disease state rather than disease sever-
ity, as an additional RDA on the subset of RSV patients
alone did not yield convincing nor significant separation
of RSV severity groups (data not shown; RDA p = 0.75).
Correspondingly, levels of Haemophilus did not differ sig-
nificantly between patient groups with distinct disease se-
verities (Fig. 6b); although in comparison to control
subjects, Haemophilus levels were higher in moderate and
severe patients than in mild.
Interestingly, based on an extended in silico analysis of
the dominant Haemophilus-level-classified OTUs detected
in this study (> 0.01% average relative abundance, n = 10),
we conclude that Haemophilus data described in this study
predominantly belongs to the species of Haemophilus influ-
enza (Additional file 2: Figure S7). The top 10 most
Fig. 3 RSV disease, viral load, and CXCL8 levels in healthy and RSV-infected individuals can be explained by nasopharyngeal microbial makeup (genus-
level). Redundancy analysis (RDA) biplots are shown. Nasopharyngeal genus-level microbiota from healthy and RSV-infected individuals are significantly
different, irrespective of disease severity (a) (according to a permutation test; p value = 0.001). Triangles are the centroids of the study sample groups: RSV
(red) and healthy control (green). RDA of RSV-infected individuals (healthy and recovery samples were excluded from analysis) shows that nasopharyngeal
genus-level microbiota can significantly be separated based on viral load (b) (Ct threshold plotted: higher Ct number corresponds to higher number of
PCR cycles before confident virus detection, hence lower viral load; p value = 0.036). For a and b, the blue arrows are the 10 best-fitting genera (names in
italic), which are the genera best explaining microbiota compositional differences between disease status (a) or different levels of RSV virus (b) as plotted
on the horizontal axis. RDA of healthy and RSV-infected individuals shows that nasopharyngeal genus-level microbiota can significantly be separated based
on levels of CXCL8 (c) (p value = 0.036; log transformation was set to 1000). The first component (horizontal axis) is optimized to explain CXCL8 level based
on microbiota relative abundances (concentration of CXCL8 in pg/μl). Correspondingly, the blue arrows are the genera (names in italic) explaining at least
5% of this variation. RDA was corrected for age, gender, and birth weight. See Additional file 2: Figure S2 for similar analysis on the OTU level
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abundant Haemophilus-classified OTUs together comprise
99.65% of the reads belonging to all 361 detected Hae-
mophilus genus OTUs (Additional file 5: Table S4). Of
these 10 OTUs, one could confidently be assigned to H.
parainfluenzae and comprise 0.25% of all reads in this
study, and two other OTUs were assigned to an unknown
cluster (0.31%). The remaining seven OTUs, the major frac-
tion of Haemophilus-assigned reads, could confidently be
assigned to H. influenza (27.7% of all reads in this study).
Other candidate taxa involved in the RDA separation, such
as Achromobacter, Veillonella, and Leptotrichia were not
highly abundant in the overall microbiome and did not cor-
relate with disease severity (Additional file 2: Figure S4). In
conclusion, RSV is marked by a strong increase in Hae-
mophilus and to lesser extent Achromobacter, but RSV dis-
ease severity cannot be related to microbiota composition.
A
B
Fig. 4 Difference in nasopharyngeal microbial community composition between healthy and RSV-infected individuals is strongly characterized by
an overrepresentation of Haemophilus. The strongest differentially abundant microbial taxa for healthy versus RSV-infected individuals are shown
in a graphical Cytoscape visualization (a) [51]. Nodes represent taxa (node size represents average relative abundance (i.e., dominance) for both
experimental groups combined); edges (dashed lines) link the different taxonomic levels. The weighed fold-change (node color) is calculated as
the 2log of the ratio of the relative abundance between healthy and RSV (0 = no difference between disease state, 1 = twice as abundant in RSV,
etc.). So, yellow to red indicates an overrepresentation during RSV infection, hence an underrepresentation in healthy infants and vice versa for
light to dark blue. The significance (node border width) is expressed as the p value of a Mann–Whitney U test, FDR-corrected for multiple testing.
The genus-level p values are listed on the right of the genera nodes. We observe a strong and significant overrepresentation of Haemophilus
genus during RSV infection (p = 0.011) (b) and of Achromobacter (p = 0.001) (Additional file 2: Figure S4A). For recovery versus RSV
samples, significance was determined using Wilcoxon signed rank test
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Fig. 5 Chemokine and cytokine levels during RSV infection. Chemokine and cytokine levels in nasopharyngeal aspirates of healthy, RSV-infected
individuals with different disease severities (a, b). In general, host responses are observed to be negatively (a) or positively (b) correlated with RSV
severity. Data is presented in pg/ml. Statistics in these plots were obtained by Kruskal–Wallis one-way ANOVA, with Dunn’s correction for multiple
testing. Significances are as follows: *p < 0.05, **p < 0.01, ***p < 0.001
A B
Fig. 6 Nasopharyngeal microbiota composition allows for separation of healthy and RSV-infected individuals. Nasopharyngeal genus-level microbiota
from healthy and RSV-infected individuals are significantly different (a). The figure shows a redundancy analysis (RDA) biplot. Triangles are the centroids
of the study sample groups: mild (yellow), moderate (orange), and severe (red) RSV and healthy control (green). The blue arrows are the 20 best-fitting
bacterial genera (names in italic), i.e., taxa that best explain the differences between the sample groups. The horizontal axis maximizes the variation in
sample groups (in contrast to a principal component analysis plot, where the variation between individual samples is maximized). In RDA, samples
(also) separated in the vertical direction indicate that this separation is (also) driven by other factors than the primary contrast, such as by individuality.
The difference in microbiota is significant (according to a permutation test; p = 0.007). We observe a strong and significant overrepresentation of
Haemophilus genus in RSV (p = 0.011; MWU, FDR-corrected) especially in moderate and severe RSV infections (b) and of Achromobacter (p = 0.001)
(Additional file 2: Figure S4A)
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Discussion
Understanding why some children develop severe bron-
chiolitis while most children experience an upper respira-
tory tract infection upon RSV infection remains essential
and needs to be answered to improve the care of RSV-
infected children in the future. Where several previous
studies focused on the microbial content involved in bron-
chiolitis, most notably by Hasegawa and coworkers, our
study exclusively focused on RSV-implicated bronchiolitis
[29, 30]. RSV disease severity is a multifactorial problem,
in which the viral load and the inflammatory response are
important drivers of disease, although this is mainly true
in previously healthy children whose airways are normal
[6, 7, 12]. An important question this study tried to an-
swer is whether nasopharyngeal microbiome composition
relates to local viral load and exerts an influence on muco-
sal immune responses. Viral load and mucosal immune
responses are thought to directly impact disease severity,
and therefore, it is difficult to disentangle these direct and
indirect effects of the microbiome on disease outcome.
The alpha diversity of the microbiota from patients with
an acute RSV infection showed a decrease in species rich-
ness but not in diversity compared to healthy infants. This
means that the number of different species reduces while
there is no difference in the distribution of the numbers of
each species. A reduced alpha diversity of the upper re-
spiratory tract has also been shown in a longitudinal co-
hort study of symptomatic rhinovirus infections in infants
(< 1 year) [31] and after administration of an intranasal
live-attenuated influenza vaccine in adults [32]. Both stud-
ies were performed prospectively and show that lower
alpha diversity is caused by viral infection and is not a pre-
requisite for viral infection. In another observational
study, comparing the microbiome during RSV and rhino-
virus infections, it was shown that there might be an asso-
ciation with different nasopharyngeal microbiome profiles,
although this has not been confirmed by others yet [33].
This suggests that the type of alteration of the microbiome
might be specific for RSV infection but also could be a
more general effect of immune system perturbation. Yet,
it is uncertain whether the observed microbiome changes
in our study are the cause or effect of RSV infection.
A multivariate redundancy analysis (RDA) could separ-
ate healthy controls from RSV-infected infants but could
not separate microbiomes based on the level of disease
severity. In the study of Steenhuijsen Piters et al., the au-
thors concluded that the microbiota composition might
affect the clinical severity, but we were unable to repro-
duce these findings, perhaps because different RSV sever-
ity measures were applied. Nevertheless, a strong and
significant overrepresentation of Haemophilus was found
in RSV-infected children, especially in severe and moder-
ate disease. In a recent study, Rosas-Salazar and co-
workers observed a similar increase of Haemophilus in
infants with acute RSV infection compared to healthy
controls and also of Streptococcus and Moraxella [34]. In
line with these and our own findings, Hasegawa and co-
workers reported that infants with RSV infection and
Haemophilus-dominant profiles had higher odds of inten-
sive care use than RSV-infected infants with profiles dom-
inated by other bacteria, such as Moraxella [30]. In the
MARC-35 bronchiolitis cohort by Mansbach and co-
workers, lower levels of Haemophilus/Moraxella were
found in the nasopharynx of RSV-infected infants in com-
parison to rhinovirus; however, this study had no data on
healthy infants [23]. Although in our studies Achromobac-
ter shows a much lower abundance than Haemophilus, it
appeared to be also dominant in RSV-infected infants.
Apart from a few studies describing the association of
Achromobacter xyloxosidans with pneumonia in new-
borns and young infants, and chronic infection in cystic
fibrosis patients, not much is known about this species
[35–37]. Much more in vitro and in vivo evidence is
present with regard to increased susceptibility for viral in-
fections and increased inflammatory responses associated
with Haemophilus colonization and infection [38–42].
However, to the best of our knowledge, this is the first
time that it is shown that the composition of the micro-
bial colonization in the nasopharynx is associated with a
higher RSV load, with Haemophilus (influenzae) as most
prominent candidate contributing to these differences
(Additional file 2: Figure S2B). Interaction of Haemophi-
lus with epithelial cells may lead to the suppression of
anti-viral immune pathways allowing increased replica-
tion. An alternative explanation would be that RSV facili-
tates the colonization of Haemophilus. However, no
evidence for any of the two hypotheses can be found in
the current literature. The Helcococcus genus, another
lead based on our reported association with levels of
CXCL8 in the NPA (Fig. 3c), is not likely to have a great
impact on its niche, as it is very lowly abundant (0.01% on
average), and is only represented by three RSV patients,
and the association was not observed at the level of
OTUs. The increase in IL6 and CXCL-8 responses in
RSV patients colonized with Haemophilus as found in
our study corroborates a recent in vitro study by Gulraiz
et al. They showed that release of IL6 and CXCL-8 after
RSV infection, but not rhinovirus infection, was synergis-
tically increased in Haemophilus influenzae pre-treated
human bronchial epithelial cells [40], suggesting that the
interaction between H. influenzae, CXCL8, and RSV may
be specific for RSV infections. It should finally be noted
that other cytokine responses than the ones studied here
might be important for RSV pathogenesis, such as T-
helper 1, T-helper 2, and T-regulatory cell type cytokines
[43]. Their potential involvement with the nasopharyngeal
microbiome during RSV pathogenesis can therefore not
be confirmed within the current study.
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Interestingly, Steenhuijsen Piters et al. recently re-
ported an enhanced (non-significant) CXCL8 gene ex-
pression response, measured in a whole blood
transcriptome analysis, that was associated with naso-
pharyngeal microbiomes that were dominated by Hae-
mophilus [24]. In our study, we are able to show a
significant association between nasopharyngeal CXCL8
levels and RSV infection and even with disease severity.
Although presence of Haemophilus was related to the
levels of CXCL8, we could not confirm a direct relation
between the composition of the microbiome and disease
severity. A possible explanation could be that although
we stratified the patients on severity level, all patients in-
cluded in our study were hospitalized and therefore se-
verely ill. The differences in disease severity might have
been too subtle to correlate them to microbial compos-
ition. In contrast to the study from Steenhuijsen Piters
et al., we chose to follow a more unbiased approach and
therefore we did not stratify for ‘nasotypes’ on forehand.
This may have led to the fact that we could not confirm
a relation between Streptococcus and disease severity. In
a previous study, we even found a reversed relation be-
tween Streptococcus pneumoniae and disease severity, al-
though this was based on qPCR data and not on 16S
sequencing [25, 44, 45]. It should also be noted that al-
though we rigorously corrected our data analyses for a
number of potential confounders (i.e., age, gender, and
birth weight), we did not have socioeconomic informa-
tion of our cohort, nor on mode-of-delivery, which can
be seen as limitation of this study.
In conclusion, although no association of the naso-
pharyngeal microbiota to disease severity was found,
we show that RSV infection affects the microbiota
composition. Haemophilus-dominated profiles were in
part associated with an increased viral load and in-
creased IL6 and CXCL-8 responses on the genus level
of, and these effects were even stronger on the level
of OTU (Haemophilus influenzae). Upon recovery,
Moraxella appears to thrive in the previously RSV-
perturbed microbiomes. A better understanding of the
mechanisms behind the influence of the microbiota
on these host-virus processes is needed and should be
the focus of future research. Improved insight in
microbiome effects on RSV pathogenesis might pave
the way for new preventive and therapeutic strategies
to reduce the burden by RSV disease.
Conclusions
Severity of RSV infection in infants is determined by
several factors. A growing body of evidence suggests that
the nasopharyngeal microbiome may play an important
role and influence both the local immune response as
well as viral load. Interactions between RSV, local muco-
sal nasopharyngeal microbial content, and the plethora
of host factors involved are not well enough understood
to explain severity of disease. This retrospective study
using a well-characterized cohort of young children with
RSV infection and age-matched healthy controls shows
for the first time that composition of nasopharyngeal
microbiota associates with CXCL8 levels in RSV pa-
tients. CXCL8 is an important chemokine that correlated
with RSV disease severity. Haemophilus was identified as
the most important genus associating with the amplitude
of the CXCL8 response. Host-microbe interactions are
increasingly recognized as important factors in deter-
mining outcome of host processes. Our findings show a
strong interdependency between the nasopharyngeal
microbiota and the mucosal immune response, poten-
tially influencing severity of disease. These data contrib-
ute to a better understanding of the importance of
commensal microbiota in respiratory health and disease.
Methods
Study design
This study was performed in two hospitals in Nijmegen,
Radboud University Medical Center and Canisius Wil-
helmina Ziekenhuis (CWZ). From the area of Nijmegen,
children younger than 2 years of age with laboratory-
confirmed RSV infections were prospectively included
during three consecutive winter seasons (2010/2011,
2011/2012, and 2012/2013), if they were hospitalized to
the pediatric ward or intensive care unit (PICU) [46].
Written informed consent was obtained from all parents.
Because the peak incidence of (severe) bronchiolitis is
below the age of 6 months, and to limit the variation in
age-related effects on microbiome and inflammatory re-
sponse, we only included the children younger than
6 months with a PCR-confirmed RSV infection. Healthy
age-matched controls admitted to the hospital for sur-
gery, who needed an elective inguinal hernia correction
and had no signs of respiratory infection and a negative
PCR for RSV, were included. We obtained permission
from the medical ethical commission of the Radboud
University Medical Center to collect control samples
during 1 year, resulting in 21 samples as used in this
study. Patients younger than 6 months with PCR-
confirmed RSV-positive bronchiolitis were selected and
divided into three groups. Children without hypoxemia
were classified as ‘mildly ill’; ‘moderately ill’ children re-
ceived supplemental oxygen, while ‘severely ill’ children
required mechanical ventilation. Patients with congenital
heart or lung disease, immunodeficiency, or glucocortic-
oid use were excluded. Within 24 h after admission, a
nasopharyngeal aspirate (NPA) was collected and par-
ents from hospitalized children were asked for permis-
sion to collect a second NPA sample 4–6 weeks after
admission (recovery). The final study cohort as reported
here existed of n = 21 healthy infants and n = 9 mild (2),
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n = 27 moderate (16), and n = 18 severe (7) patients (re-
covery samples in brackets). For more details on cohort
design, available demographics, and sample characteris-
tics, we refer to Additional file 1: Table S1.
Nasopharyngeal aspirate collection and diagnostics
The nasopharyngeal aspirates (NPA) were collected by
introducing a catheter into the nasopharyngeal cavity.
For viral diagnostics, samples were analyzed by multi-
plex PCR, quantifying 15 different viral pathogens: influ-
enza virus types A and B, coronavirus 229E and OC43,
human bocavirus, enterovirus, adenovirus, parechovirus,
PIV types 1–4, human metapneumovirus, rhinovirus
(RV), and RSV, as previously described [47]. See Add-
itional file 1: Table S1B for co-infection information of
the samples. IL-6, CXCL8, CXCL10, CCL5, and MMP9
levels were measured by ELISA as described in Add-
itional file 6: Supplementary Methods.
16S rRNA gene amplification prior to sequencing
Bacterial DNA extraction and quantification was per-
formed as previously described [48] with some modifica-
tions as reported in Additional file 6: Supplementary
Methods. To generate the PCR amplicon libraries,
sample-specific barcoded amplicons for the V3-V4 hy-
pervariable region of the small subunit ribosomal RNA
16S genes were generated using a two-step PCR. Ten to
twenty-five nanograms genomic (g)DNA was used as
template for the first PCR with a total volume of 50 μl
using the 341F (5’-CCT ACG GGN GGC WGC AG-3′)
and the 785R (5’-GAC TAC HVG GGT ATC TAA TCC-
3′) primers appended with Illumina adaptor sequences.
16S rRNA marker gene sequencing
Illumina 16S rRNA amplicon libraries were generated and
sequenced at BaseClear BV (Leiden, The Netherlands) on
an Illumina MiSeq paired-end 300 system. Sequencing data
analysis was performed by QIIME and is more elaborately
described in Additional file 6: Supplementary Methods.
The Ribosomal Database Project [49] classifier version 2.3
was performed for taxonomic classification of the sequence
reads. Alpha diversity metrics (PD whole tree, Chao1, Ob-
served Species, and Shannon) were calculated by bootstrap-
ping 4822 reads per sample and taking the average over 10
trials. Figures resulting from QIIME clustering analyses
were generated using the interactive tree of life (iTOL) tool
[50]. For visualization of the differential microbiome, Cytos-
cape software version 3.1.3 was used [51].
Statistics
For the microbiota data, statistical significance between
contrasts with regard to taxonomy abundances was
tested by a non-parametric (unpaired) Mann–Whitney
U (MWU) test, corrected with false discovery rate (FDR)
for multiple testing; unless stated otherwise. Multivariate
redundancy analysis (RDA) and principal component
analysis (PCA) was done using Canoco 5.04 [52]. For all
other experimental data (i.e., protein measurements,
metadata, etc.), statistical significance was tested likewise
using a non-parametric Kruskal–Wallis one-way
ANOVA, with Dunn’s correction for multiple testing
(GraphPad Prism 5.0), unless stated otherwise.
For a more detailed description of this materials
and methods section, we refer to Additional file 6:
Supplementary Methods.
Additional files
Additional file 1: Table S1. Participant metadata and characteristics.
(XLSX 37 kb)
Additional file 2: Figure S1. Potential confounding characteristics of
this study. Figure S2 RSV disease and viral load in healthy and RSV-
infected individuals can be explained by nasopharyngeal microbial
makeup (OTU-level). Figure S3 Species richness, but not diversity, is re-
duced in RSV-infected infants. Figure S4 Difference in Achromobacter, Veil-
lonella, and Leptotrichia abundance between healthy and RSV-infected
individuals with different disease severities. Figure S5 RSV-infected individ-
uals with mild disease symptoms display an ‘intermediate’ nasopharyn-
geal microbiota compositional profile in comparison to moderate/severe
disease and their recovery controls. Figure S6 Chemokine and cytokine
levels during RSV infection and upon recovery. Figure S7 Comparison of
OTUs from current study to Haemophilus reference species shows that
Haemophilus-classified OTUs are predominantly belonging to Haemophi-
lus influenzae species. (DOCX 968 kb)
Additional file 3: Table S2. Sample sequencing data numbers and
metrics. (XLSX 25 kb)
Additional file 4: Table S3. Sample microbiota compositional table.
(XLSX 247 kb)
Additional file 5: Table S4. Sample OTU table. (XLSX 1629 kb)
Additional file 6: Supplementary information on methods. (DOCX 20 kb)
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